Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome

Tiziano Barbui, Jürgen Thiele, Francesco Passamonti, Elisa Rumi, Emanuela Boveri, Maria Luigia Randi, Irene Bertozzi, Filippo Marino, Alessandro M. Vannucchi, Lisa Pieri, Giada Rotunno, Heinz Gisslinger, Bettina Gisslinger, Leonhard Müllauer, Guido Finazzi, Alessandra Carobbio, Andrea Gianatti, Marco Ruggeri, Ilaria Nichele, Emanuele D'AmoreAlessandro Rambaldi, Ayalew Tefferi

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

We examined the prevalence and prognostic relevance of bone marrow reticulin fibrosis in 526 patients with World Health Organization-defined polycythemia vera evaluated at the time of initial diagnosis. Seventy-four patients (14%) displayed mostly grade 1 reticulin fibrosis, with only 2 cases showing higher-grade fibrosis. Presenting clinical and laboratory characteristics, including JAK2V617F allele burden, between patients with and without fibrosis were similar for the most part, with the exception of a higher prevalence of palpable splenomegaly in patients with fibrosis (P < .01). Patients with fibrosis were less prone to experience thrombosis during their clinical course (1.1 vs 2.7 per 100 patient-years; P = .03) and more prone to develop post-polycythemia vera myelofibrosis (2.2 vs 0.8 per 100 patient-years; P = .01). There was no significant difference between the 2 groups in terms of overall or leukemia-free survival. The present study clarifies the incidence, degree, and prognostic relevance of bone marrow fibrosis obtained at time of initial diagnosis of polycythemia vera.

Original languageEnglish (US)
Pages (from-to)2239-2241
Number of pages3
JournalBlood
Volume119
Issue number10
DOIs
StatePublished - Mar 8 2012

Fingerprint

Reticulin
Polycythemia Vera
Primary Myelofibrosis
Bone
Fibrosis
Health
Splenomegaly
Leukemia
Thrombosis
Cohort Studies
Alleles
Survival

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome. / Barbui, Tiziano; Thiele, Jürgen; Passamonti, Francesco; Rumi, Elisa; Boveri, Emanuela; Randi, Maria Luigia; Bertozzi, Irene; Marino, Filippo; Vannucchi, Alessandro M.; Pieri, Lisa; Rotunno, Giada; Gisslinger, Heinz; Gisslinger, Bettina; Müllauer, Leonhard; Finazzi, Guido; Carobbio, Alessandra; Gianatti, Andrea; Ruggeri, Marco; Nichele, Ilaria; D'Amore, Emanuele; Rambaldi, Alessandro; Tefferi, Ayalew.

In: Blood, Vol. 119, No. 10, 08.03.2012, p. 2239-2241.

Research output: Contribution to journalArticle

Barbui, T, Thiele, J, Passamonti, F, Rumi, E, Boveri, E, Randi, ML, Bertozzi, I, Marino, F, Vannucchi, AM, Pieri, L, Rotunno, G, Gisslinger, H, Gisslinger, B, Müllauer, L, Finazzi, G, Carobbio, A, Gianatti, A, Ruggeri, M, Nichele, I, D'Amore, E, Rambaldi, A & Tefferi, A 2012, 'Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome', Blood, vol. 119, no. 10, pp. 2239-2241. https://doi.org/10.1182/blood-2011-11-393819
Barbui T, Thiele J, Passamonti F, Rumi E, Boveri E, Randi ML et al. Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome. Blood. 2012 Mar 8;119(10):2239-2241. https://doi.org/10.1182/blood-2011-11-393819
Barbui, Tiziano ; Thiele, Jürgen ; Passamonti, Francesco ; Rumi, Elisa ; Boveri, Emanuela ; Randi, Maria Luigia ; Bertozzi, Irene ; Marino, Filippo ; Vannucchi, Alessandro M. ; Pieri, Lisa ; Rotunno, Giada ; Gisslinger, Heinz ; Gisslinger, Bettina ; Müllauer, Leonhard ; Finazzi, Guido ; Carobbio, Alessandra ; Gianatti, Andrea ; Ruggeri, Marco ; Nichele, Ilaria ; D'Amore, Emanuele ; Rambaldi, Alessandro ; Tefferi, Ayalew. / Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome. In: Blood. 2012 ; Vol. 119, No. 10. pp. 2239-2241.
@article{34fb20983cc14dd5a30a78920d08b829,
title = "Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome",
abstract = "We examined the prevalence and prognostic relevance of bone marrow reticulin fibrosis in 526 patients with World Health Organization-defined polycythemia vera evaluated at the time of initial diagnosis. Seventy-four patients (14{\%}) displayed mostly grade 1 reticulin fibrosis, with only 2 cases showing higher-grade fibrosis. Presenting clinical and laboratory characteristics, including JAK2V617F allele burden, between patients with and without fibrosis were similar for the most part, with the exception of a higher prevalence of palpable splenomegaly in patients with fibrosis (P < .01). Patients with fibrosis were less prone to experience thrombosis during their clinical course (1.1 vs 2.7 per 100 patient-years; P = .03) and more prone to develop post-polycythemia vera myelofibrosis (2.2 vs 0.8 per 100 patient-years; P = .01). There was no significant difference between the 2 groups in terms of overall or leukemia-free survival. The present study clarifies the incidence, degree, and prognostic relevance of bone marrow fibrosis obtained at time of initial diagnosis of polycythemia vera.",
author = "Tiziano Barbui and J{\"u}rgen Thiele and Francesco Passamonti and Elisa Rumi and Emanuela Boveri and Randi, {Maria Luigia} and Irene Bertozzi and Filippo Marino and Vannucchi, {Alessandro M.} and Lisa Pieri and Giada Rotunno and Heinz Gisslinger and Bettina Gisslinger and Leonhard M{\"u}llauer and Guido Finazzi and Alessandra Carobbio and Andrea Gianatti and Marco Ruggeri and Ilaria Nichele and Emanuele D'Amore and Alessandro Rambaldi and Ayalew Tefferi",
year = "2012",
month = "3",
day = "8",
doi = "10.1182/blood-2011-11-393819",
language = "English (US)",
volume = "119",
pages = "2239--2241",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "10",

}

TY - JOUR

T1 - Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome

AU - Barbui, Tiziano

AU - Thiele, Jürgen

AU - Passamonti, Francesco

AU - Rumi, Elisa

AU - Boveri, Emanuela

AU - Randi, Maria Luigia

AU - Bertozzi, Irene

AU - Marino, Filippo

AU - Vannucchi, Alessandro M.

AU - Pieri, Lisa

AU - Rotunno, Giada

AU - Gisslinger, Heinz

AU - Gisslinger, Bettina

AU - Müllauer, Leonhard

AU - Finazzi, Guido

AU - Carobbio, Alessandra

AU - Gianatti, Andrea

AU - Ruggeri, Marco

AU - Nichele, Ilaria

AU - D'Amore, Emanuele

AU - Rambaldi, Alessandro

AU - Tefferi, Ayalew

PY - 2012/3/8

Y1 - 2012/3/8

N2 - We examined the prevalence and prognostic relevance of bone marrow reticulin fibrosis in 526 patients with World Health Organization-defined polycythemia vera evaluated at the time of initial diagnosis. Seventy-four patients (14%) displayed mostly grade 1 reticulin fibrosis, with only 2 cases showing higher-grade fibrosis. Presenting clinical and laboratory characteristics, including JAK2V617F allele burden, between patients with and without fibrosis were similar for the most part, with the exception of a higher prevalence of palpable splenomegaly in patients with fibrosis (P < .01). Patients with fibrosis were less prone to experience thrombosis during their clinical course (1.1 vs 2.7 per 100 patient-years; P = .03) and more prone to develop post-polycythemia vera myelofibrosis (2.2 vs 0.8 per 100 patient-years; P = .01). There was no significant difference between the 2 groups in terms of overall or leukemia-free survival. The present study clarifies the incidence, degree, and prognostic relevance of bone marrow fibrosis obtained at time of initial diagnosis of polycythemia vera.

AB - We examined the prevalence and prognostic relevance of bone marrow reticulin fibrosis in 526 patients with World Health Organization-defined polycythemia vera evaluated at the time of initial diagnosis. Seventy-four patients (14%) displayed mostly grade 1 reticulin fibrosis, with only 2 cases showing higher-grade fibrosis. Presenting clinical and laboratory characteristics, including JAK2V617F allele burden, between patients with and without fibrosis were similar for the most part, with the exception of a higher prevalence of palpable splenomegaly in patients with fibrosis (P < .01). Patients with fibrosis were less prone to experience thrombosis during their clinical course (1.1 vs 2.7 per 100 patient-years; P = .03) and more prone to develop post-polycythemia vera myelofibrosis (2.2 vs 0.8 per 100 patient-years; P = .01). There was no significant difference between the 2 groups in terms of overall or leukemia-free survival. The present study clarifies the incidence, degree, and prognostic relevance of bone marrow fibrosis obtained at time of initial diagnosis of polycythemia vera.

UR - http://www.scopus.com/inward/record.url?scp=84858062280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858062280&partnerID=8YFLogxK

U2 - 10.1182/blood-2011-11-393819

DO - 10.1182/blood-2011-11-393819

M3 - Article

C2 - 22246040

AN - SCOPUS:84858062280

VL - 119

SP - 2239

EP - 2241

JO - Blood

JF - Blood

SN - 0006-4971

IS - 10

ER -